SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (6089)7/2/1999 9:25:00 PM
From: Merritt  Read Replies (1) of 6136
 
Rick:
Jim McCamant of the MTSL was an early admirer of AGPH...but that doesn't necessarily make him a great analyst. He was touting IMGN at the $7 area - and all the way down...despite their being focused on a ricin-based treatment. And then there's his touting GLYC and GRPI...you won't find those two in your active data base, as they're no longer in business. I guess what I'm saying is that analysts aren't perfect, and sometimes not even close to that. I get better info here on SI than I ever did when I subscribed to the MTSL.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News